Roche to Spend $880 Million in Biologics Future; Will Inject $285 Million Into Genentech's Vacaville, Oceanside Sites, Create 250 New Jobs

Published: Oct 15, 2013

Roche isn't the only one hiring, others are hiring too! Check it out! (Isn't it tempting?)

Swiss drugmaker Roche is to invest 800 million Swiss francs ($880 million) in its global manufacturing facilities over the next five years, creating 500 jobs, as it prepares for growing demand for its biologic medicines. The world's largest maker of cancer drugs, which employs around 80,000 people in over 100 countries, said on Monday the investment would increase its production capacity in Penzberg in Germany, Basel in Switzerland and Vacaville and Oceanside in the United States. The expansion shows Roche's confidence in its development pipeline of new cancer drugs and bucks a trend of cost-cutting by some big drugmakers in recent weeks in response to slowing sales growth.

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)

Back to news